July 27, 2021
1 min watch
Save
VIDEO: Sing IMT to begin FDA trial in 2021
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Tom Ruggia, president and CEO of Samsara Vision, discusses the company’s goal of returning vision to patients blinded by late-stage age-related macular degeneration.